Overview

Prevention of Acute Pancreatitis After Endoscopic Interventions

Status:
Enrolling by invitation

Trial end date:
2021-08-01

Target enrollment:
0

Participant gender:
All

Summary

The aim of the study is to develop a method for the prevention of acute pancreatitis after minimally invasive interventions of the bile ducts using a drug regimen.

Phase:

Phase 1

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Vitebsk State Medical University

Criteria

Inclusion Criteria:

1. Patients with cholangiolithiasis.

2. Patients with benign formations of the bile ducts.

3. Patients with malignant formations of the bile ducts.

4. Patients with extrahepatic bile duct cysts.

5. Patients with biliary hypertension of unknown etiology.

6. Patients with cholangitis.

7. Patients with extrahepatic bile duct strictures.

8. Patients suffering from oncopathology of the head of the pancreas, complicated by
obstructive jaundice.

9. Patients with malignant pathology of the pancreas.

10. Patients with benign pancreatic pathology.

Exclusion Criteria:

1. ASA scale> III (severe concomitant cardiovascular pathology)

2. Severe pathology of the respiratory system.

3. Acute period of myocardial infarction.

4. Acute period of cerebral infarction.